CLINICAL_TRIALS ClinicalTrials.gov record update

Retrospective Study to Evaluate the Safety of Sebryl® and / or Sebryl Plus® in the Treatment of Seborrheic Dermatitis and Psoriasis of the Scalp in Routine Medical Practice.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05105139
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:42.456509+00:00
Published At: 2022-04-13T00:00:00+00:00
Record Updated At: 2022-04-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Seborrheic Dermatitis", "Psoriasis of Scalp"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-04-13"
protocolSection.identificationModule.nctId: "NCT05105139"
protocolSection.identificationModule.officialTitle: "Retrospective Study to Evaluate the Safety of Sebryl\u00ae and / or Sebryl Plus\u00ae in the Treatment of Seborrheic Dermatitis and Psoriasis of the Scalp in Routine Medical Practice."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.